Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Julphar
Boehringer Ingelheim
US Army
Baxter
Citi
Johnson and Johnson
US Department of Justice
Federal Trade Commission

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077277

« Back to Dashboard

NDA 077277 describes COLESTIPOL HYDROCHLORIDE, which is a drug marketed by Impax Labs and is included in two NDAs. It is available from one supplier. Additional details are available on the COLESTIPOL HYDROCHLORIDE profile page.

The generic ingredient in COLESTIPOL HYDROCHLORIDE is colestipol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Summary for 077277
Tradename:COLESTIPOL HYDROCHLORIDE
Applicant:Impax Labs
Ingredient:colestipol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 077277
Mechanism of ActionBile-acid Binding Activity
Medical Subject Heading (MeSH) Categories for 077277
Suppliers and Packaging for NDA: 077277
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277 ANDA Impax Generics 0115-5212 N 0115-5212-18
COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277 ANDA Impax Generics 0115-5212 N 0115-5212-29

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GRANULE;ORALStrength5GM/SCOOPFUL
Approval Date:May 2, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:GRANULE;ORALStrength5GM/PACKET
Approval Date:May 2, 2006TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Dow
McKinsey
Queensland Health
Daiichi Sankyo
Harvard Business School
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.